M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
- The Week’s Closed M&A Transactions:
- On June 24, 2025, THC Therapeutics, Inc (THCT: OTCQB), a $4M market cap Nevada company, engaged in the development of the dHydronator, a sanitizing herb dryer designed for drying and sanitizing freshly harvested cannabis and other herbs, completed an $11M, all stock acquisition of The Headquarters group, an Oregon and California consortium of Cannabis companies.
- The acquisition was completed at a multiple of approximately 2.3 times revenues, which seems surprisingly high for a group of companies in rather challenging markets.
- Management somewhat grandiously exclaimed that “the combined Company will serve as a vertically integrated foundation in the Company’s focused roll-up strategy to acquire industry-leading cannabis companies in the cultivation, manufacturing, distribution, and nutrients segments.” Rather strong claims for a company with no previous revenues and 15 consecutive quarters of negative EBITDA. Please excuse our snarky skepticism.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.